Charles River Laboratories International CRL
NYSE CRL
$337.40 +24.27 (+7.75%)
At close: Nov 6, 2026 · 4:00 PM EST

Charles River Laboratories International (CRL) Return on Sales [ROS] (2009 - 2026)

Updated

Charles River Laboratories International's Return on Sales [ROS] was 11.94% in Q2 2026, up 2.24 percentage points from 9.70% a year earlier but down 0.10 percentage points from the prior quarter.

Analysis

Charles River Laboratories International (CRL) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Charles River Laboratories International's Return on Sales [ROS] was 2.25% through Jun 27, 2026, down 0.84 percentage points year-over-year; for FY2025, it was 0.63%, down 4.99 percentage points from FY2024.

  • Return on Sales [ROS] has now declined for four consecutive years, with a five-year change of -14.17 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was 5.61% in FY2024 (-9.33 pp), 14.95% in FY2023 (-1.42 pp), 16.37% in FY2022 (-0.29 pp) and 16.66% in FY2021 (+1.86 pp).
  • Quarterly Return on Sales [ROS] has moved between -28.51% (Q4 2025) and 19.26% (Q2 2022) over five years.
  • Compared with a year earlier, Return on Sales [ROS] was higher in three of the last eight quarters, with an average year-over-year change of -5.79 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q1 2026 (a gain of 4.45 percentage points); the worst was Q4 2024 (a drop of 29.84 percentage points).
  • Per Business Quant data, CRL's Return on Sales [ROS] in the three quarters before Q2 2026 was 12.04% (Q1 2026), -28.51% (Q4 2025) and 13.32% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Iqvia Holdings 44.71 Bn 35.96 Bn 1.50 Bn 12.92%
2 Medpace Holdings 18.26 Bn 15.91 Bn 223.89 Mn 23.12%
3 Charles River Laboratories International 16.16 Bn 15.36 Bn 357.87 Mn 20.62%
4 Icon 16.06 Bn 12.83 Bn 491.83 Mn 9.82%
5 Fortrea Holdings 2.10 Bn 1.39 Bn 139.50 Mn 2.17%
6 Ginkgo Bioworks Holdings 699.49 Mn -62.59 Mn 18.44 Mn -290.47%
7 Evotec SE 601.99 Mn -1.16 Bn - -
8 Champions Oncology 66.71 Mn 41.80 Mn 7.70 Mn -2.69%
9 MindWalk Holdings 48.93 Mn 12.59 Mn 1.61 Mn -159.86%
10 Natural Alternatives International 6.57 Mn -21.51 Mn 1.73 Mn -38.18%
Historic Data

Historic Data

Download Data
DateValue
Sep 26, 2026 20.62%
Jun 27, 2026 11.94%
Mar 28, 2026 12.04%
Dec 27, 2025 -28.51%
Sep 27, 2025 13.32%
Jun 28, 2025 9.70%
Mar 29, 2025 7.59%
Dec 28, 2024 -16.73%
Sep 28, 2024 11.63%
Jun 29, 2024 14.78%
Mar 30, 2024 12.45%
Dec 30, 2023 13.12%
Sep 30, 2023 14.76%
Jul 1, 2023 15.56%
Apr 1, 2023 16.31%
Dec 31, 2022 14.89%
Sep 24, 2022 15.26%
Jun 25, 2022 19.26%
Mar 26, 2022 16.28%
Dec 25, 2021 19.09%
API Access

Charles River Laboratories International Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CRL&period=max&api_key=YOUR_API_KEY